Please login to the form below

Not currently logged in
Email:
Password:

Liptruzet

This page shows the latest Liptruzet news and features for those working in and with pharma, biotech and healthcare.

Merck profit slides as generics continue to bite

Merck profit slides as generics continue to bite

Merck is hoping to re-inject growth into the cholesterol franchise with the ongoing roll-out of Liptruzet (ezetimibe and atorvastatin) in the US. .

Latest news

  • Merck & Co wins green light in US for Zetia-Lipitor combo Merck & Co wins green light in US for Zetia-Lipitor combo

    Vytorin extension wins FDA approval. Merck &Co has been awarded marketing approval for Liptruzet, a new combination cholesterol treatment based on Zetia and generic atorvastatin. ... Merck is upfront about the capabilities of the new therapy, indicating

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics